Vital Care Secures Strategic Investment from Berkshire Partners and Leonard Green & Partners

Share This Post

Key Highlights

  • Vital Care partners with Berkshire Partners and Leonard Green & Partners.
  • Linden Capital Partners continues as an ongoing investor.
  • Vital Care operates 160 infusion pharmacy locations across 35 states.
  • Focus on enhancing resources and capabilities for franchisees.

Source: Business Wire

Notable Quotes

  • “We are thrilled to welcome our new partners at Berkshire and LGP. Along with our existing partners at Linden, we are excited to enhance our focus on patient care by elevating the resources and capabilities of franchisees across the country, helping them reinvest in their local markets and workforces while empowering franchisee expansion.” — Steve Foreman, CEO and President at Vital Care
  • “Throughout our discussions with the Vital Care leadership team, their commitment and sincere passion for providing patients with industry-leading infusion treatment fully resonated with us, and we are thrilled to begin our partnership alongside LGP and Linden.”  Ben Levy, Managing Director at Berkshire Partners
  • “We are excited to begin collaborating with Vital Care on key operational enhancements and the expansion of its exceptional service offerings. We are confident in our conviction that our joint investment will improve patient access of infusion services across the U.S.”  Mike Greenman, Partner at LGP

SoHC's Take

The strategic investment in Vital Care by Berkshire Partners and Leonard Green & Partners represents a significant step forward in the infusion therapy sector. With the added support and resources from these prominent private equity firms, Vital Care is well-positioned to enhance its service offerings and expand its reach across the United States. This partnership underscores the growing importance of high-quality, accessible infusion therapy services, particularly in underserved communities. As Vital Care continues to grow and innovate, the infusion therapy market is likely to see improved patient outcomes and greater access to essential treatments.

More To Explore

Total
0
Share